S&P 500   4,589.46 (+0.83%)
DOW   35,649.56 (+0.45%)
QQQ   383.79 (+1.00%)
AAPL   152.72 (+2.60%)
MSFT   323.84 (+0.21%)
FB   320.28 (+2.58%)
GOOGL   2,917.09 (-0.25%)
TSLA   1,072.50 (+3.34%)
AMZN   3,470.34 (+2.29%)
NVDA   247.62 (+1.27%)
BABA   169.82 (+0.35%)
NIO   40.60 (+3.28%)
CGC   13.00 (+1.72%)
GE   104.80 (+0.91%)
AMD   120.98 (-1.06%)
MU   69.42 (+1.73%)
T   25.61 (+2.19%)
F   16.93 (+9.16%)
ACB   6.93 (+1.32%)
DIS   170.00 (+0.27%)
PFE   43.19 (+0.51%)
BA   208.31 (+0.82%)
AMC   35.07 (+0.89%)
S&P 500   4,589.46 (+0.83%)
DOW   35,649.56 (+0.45%)
QQQ   383.79 (+1.00%)
AAPL   152.72 (+2.60%)
MSFT   323.84 (+0.21%)
FB   320.28 (+2.58%)
GOOGL   2,917.09 (-0.25%)
TSLA   1,072.50 (+3.34%)
AMZN   3,470.34 (+2.29%)
NVDA   247.62 (+1.27%)
BABA   169.82 (+0.35%)
NIO   40.60 (+3.28%)
CGC   13.00 (+1.72%)
GE   104.80 (+0.91%)
AMD   120.98 (-1.06%)
MU   69.42 (+1.73%)
T   25.61 (+2.19%)
F   16.93 (+9.16%)
ACB   6.93 (+1.32%)
DIS   170.00 (+0.27%)
PFE   43.19 (+0.51%)
BA   208.31 (+0.82%)
AMC   35.07 (+0.89%)
S&P 500   4,589.46 (+0.83%)
DOW   35,649.56 (+0.45%)
QQQ   383.79 (+1.00%)
AAPL   152.72 (+2.60%)
MSFT   323.84 (+0.21%)
FB   320.28 (+2.58%)
GOOGL   2,917.09 (-0.25%)
TSLA   1,072.50 (+3.34%)
AMZN   3,470.34 (+2.29%)
NVDA   247.62 (+1.27%)
BABA   169.82 (+0.35%)
NIO   40.60 (+3.28%)
CGC   13.00 (+1.72%)
GE   104.80 (+0.91%)
AMD   120.98 (-1.06%)
MU   69.42 (+1.73%)
T   25.61 (+2.19%)
F   16.93 (+9.16%)
ACB   6.93 (+1.32%)
DIS   170.00 (+0.27%)
PFE   43.19 (+0.51%)
BA   208.31 (+0.82%)
AMC   35.07 (+0.89%)
S&P 500   4,589.46 (+0.83%)
DOW   35,649.56 (+0.45%)
QQQ   383.79 (+1.00%)
AAPL   152.72 (+2.60%)
MSFT   323.84 (+0.21%)
FB   320.28 (+2.58%)
GOOGL   2,917.09 (-0.25%)
TSLA   1,072.50 (+3.34%)
AMZN   3,470.34 (+2.29%)
NVDA   247.62 (+1.27%)
BABA   169.82 (+0.35%)
NIO   40.60 (+3.28%)
CGC   13.00 (+1.72%)
GE   104.80 (+0.91%)
AMD   120.98 (-1.06%)
MU   69.42 (+1.73%)
T   25.61 (+2.19%)
F   16.93 (+9.16%)
ACB   6.93 (+1.32%)
DIS   170.00 (+0.27%)
PFE   43.19 (+0.51%)
BA   208.31 (+0.82%)
AMC   35.07 (+0.89%)

Nu Skin, Pacira Biosciences fall; Veoneer, Tesla rise

Monday, October 4, 2021 | The Associated Press

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:

Tesla Inc., up $6.31 to $781.53.

The electric vehicle maker's third-quarter deliveries beat Wall Street forecasts.

Guardant Health Inc., down $1.54 to $105.97.

The provider of cancer testing services reportedly decided against pursuing a potential buyout of NeoGenomics.

General Motors Co., up 85 cents to $53.98.

Activist investor Engine No. 1 reportedly took a stake in the auto maker.

Veoneer Inc., up $1.64 to $36.19.

The automotive safety technology company is being bought by Qualcomm and SSW Partners for about $4.5 billion.

Nu Skin Enterprises Inc., down 82 cents to $40.66.

The personal care products and nutritional supplements company warned investors about weak third-quarter revenue.

JELD-WEN Holding Inc., down 95 cents to $24.90.

The maker of doors and windows trimmed its forecast for revenue growth because of supply and labor problems.

ConocoPhillips, up $1.39 to $71.49.

Rising oil prices helped energy stocks move higher.

Pacira BioSciences Inc., down $7.53 to $49.45.

eVenus Pharmaceutical Laboratory is seeking authorization to make a generic version of the drug developer's post-surgical pain treatment Exparel.

Should you invest $1,000 in Tesla right now?

Before you consider Tesla, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tesla wasn't on the list.

While Tesla currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Guardant Health (GH)2.3$117.11+4.3%N/A-31.06Buy$168.64
Nu Skin Enterprises (NUS)3.5$40.33+1.4%3.77%8.88Hold$58.40
Veoneer (VNE)1.3$35.09+0.1%N/A-9.19Hold$30.27
Tesla (TSLA)2.4$1,071.00+3.2%N/A557.82Hold$695.83
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.